Intellia Therapeutics Shares | NTLA

Annual Shares Intellia Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
108 M	98.8 M	88.8 M	77 M	70.9 M	56 M	47.2 M	43.1 M	36 M	22.2 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
108 M	22.2 M	64.8 M

Quarterly Shares Intellia Therapeutics

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
133 M	118 M	110 M	104 M	104 M	102 M	101 M	97 M	95.5 M	93 M	88.6 M	88.2 M	87.8 M	87.1 M	76 M	75.8 M	74.8 M	74.5 M	73.7 M	68.2 M	67.2 M	61.3 M	58.8 M	53.4 M	50.5 M	49.4 M	48.6 M	45.8 M	45.2 M	44.2 M	43.2 M	42.8 M	42 M	39.2 M	35.2 M	34.9 M	34.7 M	34.5 M	34.3 M	19.1 M	676 K	548 K	294 K	1.28 M	1.28 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
133 M	294 K	60.9 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	2.12 M	-	-6.63 %	$ 13.9 M	USA
FSD Pharma HUGE	38.7 M	-	5743.5 %	$ 69.7 M	Canada
Synthetic Biologics SYN	12.1 M	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	130 M	-	-	$ 2.02 B	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Corner Growth Acquisition Corp. COOL	9.83 M	-	-0.89 %	$ 114 M	USA
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Qilian International Holding Group Limited QLI	113 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	4.73 M	-	1.35 %	$ 17.8 M	China
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	543 M	-	-13.47 %	$ 169 M	France
CureVac N.V. CVAC	224 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	4.28 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	9.34 B	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	229 M	-	-	$ 4.9 B	Britain
Завод ДИОД DIOD	91.5 M	-	-	-	Russia
Galera Therapeutics GRTX	98.5 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	54.9 B	-	-18.52 %	$ 27.3 M	Britain
Hepion Pharmaceuticals HEPA	9.41 M	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	48.7 M	-	1052.0 %	$ 415 M	USA
MorphoSys AG MOR	34.3 M	-	2.43 %	$ 254 M	Germany
Codexis CDXS	87.1 M	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	241 M	$ 3.78	1.89 %	$ 911 M	USA
Affimed N.V. AFMD	120 M	-	-34.95 %	$ 21.5 M	Germany
Arcutis Biotherapeutics ARQT	127 M	$ 23.9	1.01 %	$ 3.04 B	USA
Assembly Biosciences ASMB	11.2 M	$ 36.6	1.3 %	$ 410 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	38.2 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	22.6 M	-	-	$ 12.5 M	Belgium
Adial Pharmaceuticals ADIL	669 K	$ 7.12	6.91 %	$ 4.76 M	USA
Generation Bio Co. GBIO	66.6 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Cyclacel Pharmaceuticals CYCCP	2.19 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	338 M	-	-	$ 3.37 B	China
Axsome Therapeutics AXSM	49.7 M	$ 206.68	0.16 %	$ 10.3 B	USA
GlycoMimetics GLYC	27.6 M	-	9357.83 %	$ 1.01 B	USA
AnaptysBio ANAB	28.8 M	$ 56.8	0.94 %	$ 1.63 B	USA
Aeterna Zentaris AEZS	3.17 M	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	18.3 M	-	1083.1 %	$ 745 M	USA
BioMarin Pharmaceutical BMRN	192 M	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Bicycle Therapeutics plc BCYC	69.3 M	$ 4.3	1.42 %	$ 298 M	Britain
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
ChromaDex Corporation CDXC	79.2 M	-	-0.88 %	$ 598 M	USA